(Q47982205)

7 February 2018

title

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines (English)

1 reference

7 February 2018

main subject

multiple drug resistance

1 reference

1 reference

Ross DD

1

1 reference

7 February 2018

Yang W

2

1 reference

7 February 2018

Abruzzo LV

3

1 reference

7 February 2018

Dalton WS

4

1 reference

7 February 2018

Schneider E

5

1 reference

7 February 2018

Lage H

6

1 reference

7 February 2018

Dietel M

7

1 reference

7 February 2018

Greenberger L

8

1 reference

7 February 2018

Cole SP

9

1 reference

7 February 2018

Doyle LA

10

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

7 February 2018

Journal of the National Cancer Institute

published in

1 reference

7 February 2018

volume

91

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

429-433

1 reference

7 February 2018

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

cites work

1 reference

https://api.crossref.org/works/10.1093/JNCI/91.5.429

Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNCI/91.5.429

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNCI/91.5.429

Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNCI/91.5.429

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNCI/91.5.429

Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNCI/91.5.429

Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNCI/91.5.429

21 January 2018

Identifiers

DOI

10.1093/JNCI/91.5.429

1 reference

7 February 2018

release_ioyeiqoi2vggloagjrskp5y5ga

Fatcat ID

0 references

1 reference

7 February 2018